What Is Cardinal Health, Inc. (CAH) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Cardinal Health, Inc.'s intrinsic value is estimated at a composite fair value of $226.05. Trading at $233.66, the stock is approaching fair value or slight overvaluation (implied return of -3.3%), as 9 of 13 models suggest limited further upside. The most optimistic model, ML-RIV, places fair value at $762.78 (+226.4%), while EROIC — the most conservative — estimates $48.35 (-79.3%). This +305.8% gap reflects genuine analytical uncertainty about Cardinal Health, Inc.'s intrinsic worth.
What Do the Models Say About CAH?
13 of 13 models are currently active for CAH. Of these, 4 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates CAH's intrinsic value at $149.02, implying -36.2% downside from the current price. See which stocks rank higher →
How Does CAH Rank in Wholesale-Drugs, Proprietaries & Druggists' Sundries?
Among 10 Wholesale-Drugs, Proprietaries & Druggists' Sundries stocks, CAH ranks #3 by Quality of Company score. CirclFi's QOC score of 8.5/10 evaluates 32 fundamental signals. A score of 8.5 places CAH in the top tier.
Cardinal Health, Inc.'s positioning within the Wholesale-Drugs, Proprietaries & Druggists' Sundries segment means that biosimilar competition timeline plays an outsized role in fundamental analysis. The sector's unique characteristics — including regulatory pathway clarity — shape both the opportunity set and risk profile.
Is CAH a Value Trap?
CirclFi's Value Trap algorithm assigns CAH a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Cardinal Health, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Cardinal Health, Inc. scores 8.5 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +305.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CAH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CAH's 13 active models, average confidence is 42%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad